Response to the Comment on ''Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer': What Is Good for the Surgeon Is Just as Good for the Patient?'' The Case of Unresectable Pancreatic Cancer After Neoadjuvant Treatment

首页> 外文期刊>Annals of Surgery >Response to the Comment on ''Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer': What Is Good for the Surgeon Is Just as Good for the Patient?'' The Case of Unresectable Pancreatic Cancer After Neoadjuvant Treatment

【24h】

Response to the Comment on ''Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer': What Is Good for the Surgeon Is Just as Good for the Patient?'' The Case of Unresectable Pancreatic Cancer After Neoadjuvant Treatment

机译：回应关于新辅助治疗后生存率的预后因素对初始不可切除的胰腺癌的预后因素'：对外科医生的好处对患者同样好吗？“新辅助治疗后不可切除的胰腺癌的情况

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Annals of Surgery》 |2020年第4期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类外科学;
关键词

相似文献

外文文献
中文文献
专利

1. Response to the Comment on "'Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer': What Is Good for the Surgeon Is Just as Good for the Patient?'' The Case of Unresectable Pancreatic Cancer After Neoadjuvant Treatment [J] . Annals of Surgery . 2020,第4期

机译：回应关于新辅助治疗后生存率的预后因素对初始不可切除的胰腺癌的预后因素'：对外科医生的好处对患者同样好吗？“新辅助治疗后不可切除的胰腺癌的情况
2. Response to the Comment on "Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer'' [J] . Annals of Surgery . 2020,第4期

机译：回应关于“新辅助治疗后生存率的预后因素及初始不可切除的胰腺癌的生存因子”评论
3. Comment on "Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer'' [J] . Annals of Surgery . 2020,第4期

机译：评论“新辅助治疗后生存的预后因素及初始不可切除的胰腺癌患者的切除术”
4. Breast MRI radiomics for the pre-treatment prediction of response to neoadjuvant chemotherapy in node-positive breast cancer patients [C] . Karen Drukker, Iman El-Bawab, Alexandra Edwards, SPIE Conference on Computer-Aided Diagnosis . 2019

机译：乳腺MRI辐射射清，用于节点阳性乳腺癌患者对新辅助化疗的反应预处理预测
5. APE1/Ref-1 Redox Signaling Regulates HIF1a-Mediated CA9 Expression in Hypoxic Pancreatic Cancer Cells: Combination Treatment in Patient-Derived Pancreatic Tumor Models [D] . Logsdon, Derek Paul. 2018

机译：APE1 / Ref-1氧化还原信号调节低氧胰腺癌细胞中HIF1a介导的CA9表达：患者源性胰腺肿瘤模型的联合治疗
6. The preoperative modified Glasgow prognostic score for the prediction of survival after pancreatic cancer resection following non-surgical treatment of an initially unresectable disease [O] . Shinichi Ikuta, Takashi Sonoda, Tsukasa Aihara, 2018

机译：术前改良的格拉斯哥预后评分用于预测非手术治疗最初无法切除的疾病后胰腺癌切除术后的存活率
7. Table 5.5.a.1 Tumor size and treatment (rate of resectability) Figure 5.5.a.2 Cumulative survival of the patients after pancreatectomy for TS1 cancer according to residual tumors Figure 5.5.a.3 Cumulative survival of the patients with TS1 cancer according to extent of lymph node dissection Figure 5.5.a.4 Combined resection of portal vein and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.5 Combined resection of peripancreatic plexus and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.6 Combined resection of peripancreatic plexus when there is no plexus infiltration and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.7 Combined resection of artery and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.8 Combined resection of portal vein and cumulative survival of the patients after pancreatectomy for TS2 (2.1-4.0 cm) cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.9 Combined resection of peripancreatic plexus and cumulative survival of the patients after pancreatectomy for TS2 (2.1-4.0 cm) cancer of UICC Stage IIa or IIb in the pancreatic head [O] . 2007

机译：表5.5.a.1肿瘤大小和治疗（重新切性率）图5.5.a.2根据残留肿瘤对TS1癌胰腺切除后患者的累积存活图5.5.A.3累积存活根据淋巴结解剖的程度，TS1癌症的患者图5.5.A.4在胰头胰腺IIA或IIB癌症术后胰岛切除术后的门静脉和累积患者的累积存活图5.5。 A.5在胰头术后IIA或IIB胰腺切除术后，患者胰腺癌丛和患者累积存活的组合图5.5.A.6当没有丛浸润时，围裙丛生的围嘴巴丛的切除胰腺切除术后胰腺切除术后胰腺炎癌症的累积存活图5.5.A.7在TS1癌症胰腺切除后患者的动脉和累积存活的组合UICC阶段IIA或IIB在胰头图5.5.A.8在胰头胰腺阶段IIA或IIB癌症的胰腺切除后，患者的门静脉和累积患者的累积存活率图5.5.A.9在胰头胰腺阶段IIA或IIB的胰腺切除术后胰腺切除术后患者患者患者患者的累积生存的组合和胰腺头

Response to the Comment on ''Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer': What Is Good for the Surgeon Is Just as Good for the Patient?'' The Case of Unresectable Pancreatic Cancer After Neoadjuvant Treatment

著录项

相似文献

相关主题

期刊订阅